David Tougeron

Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability

Bernhard Mlecnik, Gabriela Bindea, Helen K. Angell et al. · Immunity · 2016 · 1K citations · Full text

Tumor Biology, Medicine, Immunology +9

Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study

Julien Edeline, M. Benabdelghani, Aurélie Bertaut et al. · Journal of Clinical Oncology · 2019 · 504 citations

Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability–High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study

Thierry André, David Tougeron, Guillaume Piessen et al. · Journal of Clinical Oncology · 2022 · 345 citations · Full text

Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma

Julien Edeline, Yann Touchefeu, Boris Guiu et al. · JAMA Oncology · 2019 · 277 citations · Full text

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

B. Sangro, Stephen L. Chan, Robin Kate Kelley et al. · Annals of Oncology · 2024 · 254 citations · Full text